Fludarabine, Mitoxantrone and Cyclophosphamide (FMC) for T-CLL (T-cell chronic lymphocytic leukaemia) and T-PLL (T-cell prolymphocytic leukemia) followed by Campath 1 St
| Type of clinical trial
|
Protocol clinical trial |
| Recruiting project
|
No
|
| Orpha number
|
ORPHA57726 |
| Status
|
Ongoing trial
|
| Website
|
|
| Geographic coverage
|
National |
| Funding body(ies)
|
- |
| Sponsor
|
- |
|
Principal investigator of clinical trial :
Dr Georg HOPFINGER
Ludwig Boltzmann Institut für Leukämieforschung und Hämatologie
Hanusch Krankenhaus
Heinrich Collinstraße 30
1140 WIEN
AUSTRIA
More information
|
Phone
: 43 1 91021 85503
Fax
: 43 1 91021 85509
Website
|
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.
